PEDIATRIC MALIGNANT SOLID TUMOR AND EPITHELIOID SARCOMA

Clinical trials for PEDIATRIC MALIGNANT SOLID TUMOR AND EPITHELIOID SARCOMA explained in plain language.

Never miss a new study

Get alerted when new PEDIATRIC MALIGNANT SOLID TUMOR AND EPITHELIOID SARCOMA trials appear

Sign up with your email to follow new studies for PEDIATRIC MALIGNANT SOLID TUMOR AND EPITHELIOID SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new drug shrink Hard-to-Treat childhood cancers?

Disease control Not yet recruiting

This trial is testing an experimental drug called ONO-4538HSC (nivolumab) in children with advanced solid tumors that have not responded to standard treatments, and in patients with epithelioid sarcoma. The goal is to see if the drug is safe, tolerable, and effective at shrinking…

Matched conditions: PEDIATRIC MALIGNANT SOLID TUMOR AND EPITHELIOID SARCOMA

Phase: PHASE1, PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC

PEDIATRIC MALIGNANT SOLID TUMOR AND EPITHELIOID SARCOMA

Get alerted when new PEDIATRIC MALIGNANT SOLID TUMOR AND EPITHELIOID SARCOMA trials appear

Can a new drug shrink Hard-to-Treat childhood cancers?